FIELD: medicine; immunology.
SUBSTANCE: group of inventions relates to medicine, specifically to immunology, and can be used to obtain a vaccine against herpes simplex virus (HSV). Drug comprises a pharmaceutically acceptable carrier and a polypeptide comprising amino acid sequence of SEQ ID NO. 2 or amino acid sequence SEQ ID NO. 2, wherein 1-20 amino acids are absent from N-terminus, C-terminus or both. Group of inventions also relates to use of isolated polypeptides for preparing a medicament for treating a patient from herpes simplex virus infection.
EFFECT: use of this group of inventions enables to use isolated polypeptides represented by SEQ ID NO 2 separately or in a combination with SEQ ID NO 4 and SEQ ID NO 5 as an effective vaccine.
138 cl, 16 tbl, 6 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| STREPTOCOCCUS PNEUMONIAE VACCINES AND COMPOSITIONS | 2010 |
|
RU2580299C2 |
| VACCINES AND COMPOSITION AGAINST STREPTOCOCCUS PNEUMONIAE | 2012 |
|
RU2623174C2 |
| IMMUNOGENIC COMPOSITIONS AND METHODS | 2008 |
|
RU2468034C2 |
| COMPOSITIONS AND METHODS OF TREATING FUNGAL AND BACTERIAL PATHOGENS | 2014 |
|
RU2717306C2 |
| COMPOSITIONS AND METHODS FOR TREATING CYTOMEGALOVIRUS | 2012 |
|
RU2737530C1 |
| COMPOSITIONS AND METHODS FOR TREATING ACTIVE MYCOBACTERIUM TUBERCULOSIS INFECTION | 2013 |
|
RU2659149C2 |
| CANINE BABESIOSIS VACCINE ANTIGEN | 2011 |
|
RU2599544C2 |
| IMMUNOGENIC COMPOSITIONS FOR IMMUNIZATION OF PIGS AGAINST CIRCOVIRUS TYPE 3 AND METHODS OF PRDUCTION AND APPLICATION THEREOF | 2016 |
|
RU2744193C2 |
| IMMUNOGENS FOR VACCINATION AGAINST HIV | 2013 |
|
RU2648791C2 |
| CURTAILED SECRETABLE ASPARTYL-PROTEINASE 2 | 2008 |
|
RU2493255C2 |
